Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
    February 2021
  1. WANG Q, Gao H, Clark KM, Mugisha CS, et al
    CARD8 is an inflammasome sensor for HIV-1 protease activity.
    Science. 2021 Feb 4. pii: science.abe1707. doi: 10.1126/science.abe1707.
    >> Share

    January 2021
  2. RAPPAZZO CG, Tse LV, Kaku CI, Wrapp D, et al
    Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Science. 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.
    >> Share

  3. HIE B, Zhong ED, Berger B, Bryson B, et al
    Learning the language of viral evolution and escape.
    Science. 2021;371:284-288.
    >> Share

    December 2020
    HIV researcher named to lead battered CDC.
    Science. 2020;370:1256.
    >> Share

    November 2020
  5. ROARK RS, Li H, Williams WB, Chug H, et al
    Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.
    Science. 2020 Nov 19. pii: science.abd2638. doi: 10.1126/science.abd2638.
    >> Share

    October 2020
  6. BESTER SM, Wei G, Zhao H, Adu-Ampratwum D, et al
    Structural and mechanistic bases for a potent HIV-1 capsid inhibitor.
    Science. 2020;370:360-364.
    >> Share

  7. CHRISTENSEN DE, Ganser-Pornillos BK, Johnson JS, Pornillos O, et al
    Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro.
    Science. 2020;370.
    >> Share

    September 2020
  8. BASTARD P, Rosen LB, Zhang Q, Michailidis E, et al
    Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4585. doi: 10.1126/science.abd4585.
    >> Share

  9. ZHANG Q, Bastard P, Liu Z, Le Pen J, et al
    Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4570. doi: 10.1126/science.abd4570.
    >> Share

  10. WOROBEY M, Pekar J, Larsen BB, Nelson MI, et al
    The emergence of SARS-CoV-2 in Europe and North America.
    Science. 2020 Sep 10. pii: science.abc8169. doi: 10.1126/science.abc8169.
    >> Share

    August 2020
  11. COHEN J
    How 'elite controllers' tame HIV without drugs.
    Science. 2020;369:1045.
    >> Share

    July 2020
  12. ABDOOL KARIM Q, Abdool Karim SS
    COVID-19 affects HIV and tuberculosis care.
    Science. 2020;369:366-368.
    >> Share

  13. LV Z, Deng YQ, Ye Q, Cao L, et al
    Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
    Science. 2020 Jul 23. pii: science.abc5881. doi: 10.1126/science.abc5881.
    >> Share

  14. YUAN M, Liu H, Wu NC, Lee CD, et al
    Structural basis of a shared antibody response to SARS-CoV-2.
    Science. 2020 Jul 13. pii: science.abd2321. doi: 10.1126/science.abd2321.
    >> Share

  15. VILLABONA-ARENAS CJ, Hall M, Lythgoe KA, Gaffney SG, et al
    Number of HIV-1 founder variants is determined by the recency of the source partner infection.
    Science. 2020;369:103-108.
    >> Share

    June 2020
  16. ROGERS TF, Zhao F, Huang D, Beutler N, et al
    Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.
    Science. 2020 Jun 15. pii: science.abc7520. doi: 10.1126/science.abc7520.
    >> Share

  17. WEC AZ, Wrapp D, Herbert AS, Maurer DP, et al
    Broad neutralization of SARS-related viruses by human monoclonal antibodies.
    Science. 2020 Jun 15. pii: science.abc7424. doi: 10.1126/science.abc7424.
    >> Share

    May 2020
  18. BEKKER LG, Mizrahi V
    COVID-19 research in Africa.
    Science. 2020;368:919.
    >> Share

  19. VASAVDA C, Ho BK, Snyder SH
    Ease restrictions on U.S. blood donations.
    Science. 2020;368:957.
    >> Share

  20. COHEN J
    Long-acting drug acts like a short-term AIDS vaccine.
    Science. 2020;368:807.
    >> Share

  21. COHEN MS, Corey L
    Combination prevention for COVID-19.
    Science. 2020;368:551.
    >> Share

    April 2020
  22. BROWN JD, Kharytonchyk S, Chaudry I, Iyer AS, et al
    Structural basis for transcriptional start site control of HIV-1 RNA fate.
    Science. 2020;368:413-417.
    >> Share

    Tested by HIV and TB, South Africa confronts new pandemic.
    Science. 2020;368:117.
    >> Share

    February 2020
  24. COHEN J
    Combo of two HIV vaccines fails its big test.
    Science. 2020;367:611-612.
    >> Share

    January 2020
  25. COOK NJ, Li W, Berta D, Badaoui M, et al
    Structural basis of second-generation HIV integrase inhibitor action and viral resistance.
    Science. 2020 Jan 30. pii: science.aay4919. doi: 10.1126/science.aay4919.
    >> Share

  26. PASSOS DO, Li M, Jozwik IK, Zhao XZ, et al
    Structural basis for strand transfer inhibitor binding to HIV intasomes.
    Science. 2020 Jan 30. pii: science.aay8015. doi: 10.1126/science.aay8015.
    >> Share

    December 2019
  27. HUFFMAN MA, Fryszkowska A, Alvizo O, Borra-Garske M, et al
    Design of an in vitro biocatalytic cascade for the manufacture of islatravir.
    Science. 2019;366:1255-1259.
    >> Share

  28. AGAZIO A, Torres RM
    Ushering along B cells to neutralize HIV.
    Science. 2019;366:1197-1198.
    >> Share

  29. SAUNDERS KO, Wiehe K, Tian M, Acharya P, et al
    Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.
    Science. 2019;366.
    >> Share

    November 2019
  30. COHEN J, Kaiser J
    Gates and NIH join forces on HIV and sickle cell diseases.
    Science. 2019;366:558-559.
    >> Share

    October 2019
  31. STEICHEN JM, Lin YC, Havenar-Daughton C, Pecetta S, et al
    A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
    Science. 2019 Oct 31. pii: science.aax4380. doi: 10.1126/science.aax4380.
    >> Share

    September 2019
  32. ABBINK P, Mercado NB, Nkolola JP, Peterson RL, et al
    Lack of therapeutic efficacy of an antibody to alpha4beta7 in SIVmac251-infected rhesus macaques.
    Science. 2019;365:1029-1033.
    >> Share

  33. BERG J
    Editorial expression of concern.
    Science. 2019;365:991.
    >> Share

  34. IWAMOTO N, Mason RD, Song K, Gorman J, et al
    Blocking alpha4beta7 integrin binding to SIV does not improve virologic control.
    Science. 2019;365:1033-1036.
    >> Share

  35. DI MASCIO M, Lifson JD, Srinivasula S, Kim I, et al
    Evaluation of an antibody to alpha4beta7 in the control of SIVmac239-nef-stop infection.
    Science. 2019;365:1025-1029.
    >> Share

    August 2019
  36. AMAMBUA-NGWA A, Amenga-Etego L, Kamau E, Amato R, et al
    Major subpopulations of Plasmodium falciparum in sub-Saharan Africa.
    Science. 2019;365:813-816.
    >> Share

  37. COHEN J
    Cancer therapy returns to original target: HIV.
    Science. 2019;365:530.
    >> Share

  38. Erratum for the Report: "Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells" by V. Ramsuran, V. Naranbhai, A. Horowitz, Y. Qi, M. P. Martin, Y. Yuki, X. Gao, V. Walker-Sperling, G. Q. Del Prete, D. K. Schneider,
    Science. 2019;365.
    >> Share

    July 2019
  39. COHEN J
    Once-a-year implant shows promise against HIV.
    Science. 2019;365:309.
    >> Share

  40. RAMAN AS, Gehrig JL, Venkatesh S, Chang HW, et al
    A sparse covarying unit that describes healthy and impaired human gut microbiota development.
    Science. 2019;365.
    >> Share

    June 2019
  41. STONE R
    North Korea's HIV epidemic emerges from the shadows.
    Science. 2019;364:1215-1216.
    >> Share

    May 2019
  42. LI G, Jiang Y, Zhang L
    HIV upsurge in China's students.
    Science. 2019;364:711.
    >> Share

  43. GAIHA GD, Rossin EJ, Urbach J, Landeros C, et al
    Structural topology defines protective CD8(+) T cell epitopes in the HIV proteome.
    Science. 2019;364:480-484.
    >> Share

  44. MCMICHAEL AJ, Carrington M
    Topological perspective on HIV escape.
    Science. 2019;364:438-439.
    >> Share

    March 2019
  45. COHEN J
    Tests identify HIV's final redoubt.
    Science. 2019;363:1260-1261.
    >> Share

  46. COHEN J
    Giant prevention study has sobering message.
    Science. 2019;363:1132.
    >> Share

  47. COHEN J
    Has a second person with HIV been cured?
    Science. 2019;363:1021.
    >> Share

    February 2019
    Unexpected drug emerges for stroke recovery.
    Science. 2019;363:805.
    >> Share

  49. COHEN J
    AIDS push gets mixed reviews.
    Science. 2019;363:680.
    >> Share

    December 2018
  50. SCHONEBERG J, Pavlin MR, Yan S, Righini M, et al
    ATP-dependent force generation and membrane scission by ESCRT-III and Vps4.
    Science. 2018;362:1423-1428.
    >> Share

  51. TOKATLIAN T, Read BJ, Jones CA, Kulp DW, et al
    Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.
    Science. 2018 Dec 20. pii: science.aat9120. doi: 10.1126/science.aat9120.
    >> Share

  52. COHEN J
    U.N. HIV/AIDS agency assailed for culture of harassment.
    Science. 2018;362:1224.
    >> Share

    For China, a CRISPR first goes too far.
    Science. 2018;362:1091.
    >> Share

  54. COHEN J
    What now for human genome editing?
    Science. 2018;362:1090-1092.
    >> Share

    August 2018
  55. COHEN J
    Monthly shots may replace daily anti-HIV pills.
    Science. 2018;361:740.
    >> Share

    June 2018
  56. COHEN J
    Babies who dodge HIV may not be unscathed.
    Science. 2018;360:1168.
    >> Share

  57. ABDOOL KARIM Q, Abdool Karim SS
    HIV-No time for complacency.
    Science. 2018;360:1153.
    >> Share

  58. COHEN J
    The Sunshine State's dark cloud.
    Science. 2018;360:1176-1179.
    >> Share

  59. COHEN J
    The loyal opposition.
    Science. 2018;360:1175.
    >> Share

  60. COHEN J
    The pill exchange.
    Science. 2018;360:1174.
    >> Share

  61. COHEN J
    Poster couple.
    Science. 2018;360:1172.
    >> Share

  62. COHEN J
    Status symbol.
    Science. 2018;360:1171.
    >> Share

  63. COHEN J
    Dark nights, bright stars.
    Science. 2018;360:1170-1175.
    >> Share

    March 2018
  64. COHEN J
    Concern as HIV prevention strategy languishes.
    Science. 2018;359:1205.
    >> Share

    January 2018
  65. RAMSURAN V, Naranbhai V, Horowitz A, Qi Y, et al
    Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.
    Science. 2018;359:86-90.
    >> Share

    October 2017
  66. WENDER PA, Hardman CT, Ho S, Jeffreys MS, et al
    Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Science. 2017;358:218-223.
    >> Share

  67. COHEN MS, Corey L
    Broadly neutralizing antibodies to prevent HIV-1.
    Science. 2017;358:46-47.
    >> Share

    September 2017
  68. XU L, Pegu A, Rao E, Doria-Rose N, et al
    Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Science. 2017 Sep 20. pii: eaan8630. doi: 10.1126/science.aan8630.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016